Seres Therapeutics, Inc. Share Price
NASDAQ: MCRB | Micro CapSeres Therapeutics, Inc. Stock Performance
Seres Therapeutics, Inc. Share Price Today
As of 31 October 2026, Seres Therapeutics, Inc.'s share price is $1.77. The stock opened at $1.84, compared to its previous close of $1.95. During today's trading session, Seres Therapeutics, Inc.'s share price traded between $1.75 and $1.84, with an average price of $1.80. Over the past 52 weeks, the stock has recorded a high of $29.59 and a low of $1.68. In terms of performance, Seres Therapeutics, Inc.'s share price has declined by 76.18% over the last six months and is down 89.21% on a year-on-year basis.
Seres Therapeutics, Inc. Share Price Chart
Seres Therapeutics, Inc. Quarterly Profit & Loss
All figures in USD
Seres Therapeutics, Inc. Annual Profit & Loss
All figures in USD
About Seres Therapeutics, Inc.
Seres Therapeutics Inc is a clinical-stage biotechnology company focused on the development of live biotherapeutic candidates. Its pipeline includes candidates such as SER-155 and SER-603, aimed at preventing and treating bacterial infections, antimicrobial resistance, and gastrointestinal immune diseases. The company operates as a single reportable segment, mainly developing microbiome-based therapies targeting bacterial infections, antimicrobial resistance, and gastrointestinal immune diseases.
Seres Therapeutics, Inc. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Oct 2026 | $3.19 | $1.76 | -47.77% |
Sep 2026 | $4.96 | $3.37 | -32.33% |
Aug 2026 | $4.97 | $4.98 | +5.06% |
Jul 2026 | $7.76 | $4.74 | -39.85% |
Jun 2026 | $7.39 | $7.88 | +6.92% |
May 2026 | $7.45 | $7.37 | -0.81% |
Apr 2026 | $9.20 | $7.43 | -16.52% |
Mar 2026 | $8.89 | $8.90 | +1.71% |
Feb 2026 | $15.00 | $8.75 | -40.58% |
Jan 2026 | $14.99 | $14.72 | -0.77% |
Dec 2025 | $18.05 | $14.84 | -17.74% |
Nov 2025 | $16.38 | $18.04 | +10.00% |